Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia

Clinical trial NCT00054431 · COMPLETED

Trial details

NCT number: NCT00054431
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Accelerated Phase Chronic Myelogenous Leukemia Blastic Phase Chronic Myelogenous Leukemia Childhood Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Relapsing Chronic Myelogenous Leukemia

Start date: 2003-01-01
Primary completion: 2007-05-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.